NCT04935268

Brief Summary

The study of demographics and risk factors for abdominal aortic aneurysms, allows to individualize treatment approaches. Determining of the results of treatment of patients who requires a late open conversion after EVAR will allow to develop the surgical approach and the selection of the optimal type of surgical treatment. Determination of genetic polymorphisms will reduce the number of postoperative complications by predicting of possible complications in the long term period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 15, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 22, 2021

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

November 18, 2023

Status Verified

August 1, 2022

Enrollment Period

2.5 years

First QC Date

June 15, 2021

Last Update Submit

November 15, 2023

Conditions

Aortic Aneurysm, Abdominal

Outcome Measures

Primary Outcomes (1)

  • Survival

    Mortality

    1-60 Month

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients wit infrarenal Aortic Aneurysms

You may qualify if:

  • Infrarenal Aortic Aneurysm

You may not qualify if:

  • Other Aneurysms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Egan Kalmykov

Frechen, Please Select, 50226, Germany

Location

MeSH Terms

Conditions

Aortic Aneurysm, Abdominal

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Study Officials

  • Igor A Suchkov, Prof

    Ryazan State Medical University

    STUDY DIRECTOR

  • Egan Kalmykov, Dr

    Clinic of Vascular Surgery, Frechen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
60 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2021

First Posted

June 22, 2021

Study Start

May 1, 2021

Primary Completion

November 1, 2023

Study Completion

November 1, 2023

Last Updated

November 18, 2023

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will share

There is a plan to make IPD and related data dictionaries available.

Shared Documents
SAP, CSR

Locations

DE(1)